Central Trust Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Central Trust Company’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17	Closed	-$3K	–	1183
2018 Q3	$3K	Hold	17	–	–	﹤0.01%	1156
2018 Q2	$2K	Hold	17	–	–	﹤0.01%	1183
2018 Q1	$2K	Hold	17	–	–	﹤0.01%	1200
2017 Q4	$2K	Sell	17 -183	-92%	-$22.6K	﹤0.01%	1195
2017 Q3	$25K	Buy	+200	New	+$23.7K	﹤0.01%	802

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Central Trust Company's FBT Position: Q4 2018 in Review

Central Trust Company sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 17 shares — an estimated $3K sold.

Central Trust Company first reported a position in FBT in Q3 2017 and held it in 5 quarters. The position peaked at $25K in Q3 2017. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

Central Trust Company reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
Central Trust Company sold 17 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $3K.
Central Trust Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and held it in 5 quarters.
Central Trust Company's First Trust NYSE Arca Biotechnology Index Fund position peaked at $25K in Q3 2017.
194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Central Trust Company's 13F filing for Q4 2018, filed 8 Jan 2019.